![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Medicago and InterveXion Team Up to Develop Drug Abuse Therapies
Medicago and InterveXion Team Up to Develop Drug Abuse Therapies
Medicago and InterveXion Therapeutics have formed a multi-year product co-development collaboration, which will use Medicago's Proficia Protein Technology for the production of monoclonal antibodies therapeutics designed to treat drug abuse. InterveXion has received a $3 million grant to conduct clinical trials for the first antibody treatment for addiction to the drug phencyclidine, or PCP.
()a href="http://www.pharmaceutical-business-review.com/article_news.asp?guid=EFC49A98-244A-4CE3-BA97-D49C5AB58917" target="_blank">Pharmaceutical Business Review Online
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct